WinstonWınston
Encompass Health Corporation logo

Encompass Health Corporation

EHC
60
Medical - Care Facilities · Healthcare
Price
$112.21
-0.28 (-0.25%)
Market Cap
$11.13B
Winston Score
60
Winston is curious
A decent business — some strong pillars, some weaker.

Share count rising — dilution

+2.0% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 100.2M (2021) → 102.2M (2025)

Encompass Health runs a network of inpatient rehabilitation hospitals across the United States. These hospitals help patients recover from serious medical events like strokes, hip fractures, brain injuries, and spinal cord damage. It is the largest operator of inpatient rehabilitation facilities in the country, with over 160 hospitals in roughly 40 states.

The company makes money by charging for patient stays, with most payments coming from Medicare, Medicaid, and private insurance. Because building and staffing specialized rehab hospitals requires significant expertise and capital, new competitors have a hard time entering the market quickly. The aging U.S. population is a key growth driver, since older adults are more likely to need rehabilitation services after illness or injury. However, the company depends heavily on Medicare reimbursement rates, so any cuts to government healthcare payments would directly hurt its revenue.

Winston Score History

Politician Trades

4 trades / 12mo

2 Congressional buys and 2 sells on EHC in the last 12 months.

Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.

Unlock politician trades

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+9.0% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+30.7% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

1.3%ownership

Flat

Insiders holding steady — not selling despite ability to

Cash Position

Cash flow positive

$163M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Encompass Health Corporation is growing revenue at 9% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
48.4%
Healthy — 48.4% gross margin
Operating Margin
19.0%
Healthy — 19.0% operating margin
ROCE
6.5%
Weak — 6.5% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+10.0%
Steady sales growth (10.0% YoY)
EPS YoY
+23.8%
Earnings growing fast (23.8% YoY)

Healthy double-digit earnings growth — what compounders look like.

EPS Consistency
8/8 quarters
Every recent quarter grew earnings vs last year

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
197%
Turns 197% of profit into real cash
FCF Margin
7.7%
Modest free cash flow (7.7%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.84
Moderate — manageable debt (0.84)
Interest Cover
8.83x
Comfortably covers interest (8.8x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
18.5x
Fair value — P/E 18.5

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

P/E vs Forward
+4.5
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (18.5 → 13.9)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend Yield
0.73%
Small dividend — 0.73% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend Growth
+11.8%
Dividend growing fast (11.8% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial